U.S. Turns from Assault Ships to Mini-Aircraft Carriers
Fewer troops, more planes
She's 844 feet long, 106 feet wide and displaces 45,000 tons of water. The future USS America, christened in Mississippi on Saturday, is technically an amphibious assault ship, a type of vessel optimized for carrying Marines into battle. But subtle changes under America's steel skin mean she can double as a small aircraft carrier, capable of sustaining a short air war all on her own.
The changes to America and her sister ship Tripoli came at the cost of some of the usual amphibious capabilities possessed by assault ships. By investing a combined $6 billion in America and Tripoli, the Navy and Marines are betting that future warfare will involve more aerial combat and fewer potential beach assaults.
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post comments
The controversial "death pathway" has come under renewed attack from doctors, lawyers and campaigners who said staff using it had to guess when patients were nearing the end of life coach outlet The Liverpool Care Pathway is aimed at providing a comfortable death for patients in their last days and hours by not subjecting them to futile treatments, but many fear it is being used inappropriately and has become "self-fulfilling". coach outlet online In their response to the agreement, the group opposing the pathway, led by Prof Patrick Pullicino, a neurologist from East Kent Hospitals, argued that it was fatally flawed.